Sharechat Logo

Green Cross Health Limited (NZX: GXH) Full Year Results to 31 March 2021

Friday 28th May 2021

Text too small?

Listed primary healthcare provider Green Cross Health, the Group behind Unichem and Life Pharmacy, The Doctors and Access Community Health, reported Net Profit After Tax Attributable to Shareholders of $16.8 million was in line with the underlying prior year result and includes growth in the Medical and Community Health divisions, offsetting retail softness in the Pharmacy division.

Future Focus and Dividend

Whilst the Board accepts there is still some uncertainty ahead, it is pleased with how the Company has weathered the COVID-19 uncertainties, producing both a solid profit performance and performing an important primary healthcare role for the community in the most trying of times.

The Company continues to engage with District Health Boards and the Ministry of Health, highlighting our ability and willingness to play an increased role in the COVID-19 vaccine programme as it extends to all New Zealanders.

Green Cross Health is committed to meeting patient and customer expectations, providing all New Zealanders accessible, quality primary healthcare. As part of this commitment, we are advocating for the removal of the prescription co-payment Government tax and are expectant that the implementation of the New Zealand Health & Disability System Reforms will see the improved accessibility and affordability of primary healthcare for New Zealand communities.

The Board has decided not to declare a final FY21 dividend in order to preserve cash to assist the Company with accelerating its acquisition activities.

Please see the links below for details

GXH Media Release 31 March 2021

GXH Financial Statements 31 March 2021

GXH Annual Results Presentation 31 March 2021

GXH NZX appendix 1 31 March 2021

Source: Green Cross Health Limited

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

BIF - Acquires shares in Hot Lime Labs
RUA - Cann Group granted TGA GMP for Mildura facility
AFI - Invitation to Results Webcast
PFI Share Buyback Programme to Pause
Greenfern Industries Limited ("GFI") - Late Annual Report
FSF - Monthly Allotment/ Redemption Notice
1st July 2022 Morning Report
General Capital Releases 2022 Annual Report
Fonterra, NZX, EEX confirm GDT strategic partnership
BIF - Annual Report 2022